Sonny Patel
← All work
Orena · 2025 – present

Designing an AI-assisted cognitive health product under real-world constraints

Problem
Adults over 50 worry about cognitive decline, but clinical testing is expensive and reactive, and consumer tools are shallow or alarmist.
My role
Led end-to-end: discovery, product strategy, AI system design, UX, acquisition, onboarding, payments and clinician-review workflows.
Timeframe
At-home kit MVP in 2025; now a fully digital service.
Outcome
Current offer: a $299 cash-pay assessment with a 1:1 neurologist results consultation and guidance on further evaluation.
The problem

“Am I okay, and what should I do next?”

Users weren’t asking for diagnoses. Raw scores and medical language created anxiety without clarity, while clinics lack capacity for proactive screening.

The product question: how might we deliver early cognitive insight that feels trustworthy, understandable and safe, without overstepping into diagnosis or medical authority?

Constraints as design inputs

What the product could not do

  • No diagnosis or medical claims (regulatory risk)
  • No black-box AI decisions (trust risk)
  • No overwhelming data or alarming language (emotional risk)
  • Must work for non-technical older adults
  • Must be viable as a direct-to-consumer product
Version 1 · At-home kit, 2025

Assessment first, AI second

I grounded insights in validated cognitive tasks and used AI only for explanation and synthesis. AI alone can sound confident, but confidence without grounding is dangerous in health contexts.

The tradeoff: slower to build than pure AI analysis and less “wow” upfront, in exchange for much higher interpretability and safety. AI explains and contextualizes results; it does not decide them.

1 · Validated tasks
01Word recall✓
02Trail making✓
03Reaction time✓
At-home kit · completed
2 · Scored by rules
MemoryTypical range
AttentionTypical range
Executive functionTypical range
Deterministic · same input, same result
3 · AI explains
Plain-language summary
Your results sit within the typical range for memory, attention and planning.Attention was a relative strength. A good next step is to repeat the check in six months.
Explains the result, doesn’t decide it
Validated tasks produce the scores. AI only turns them into plain language.

Insight framing over raw scores

Results are framed by cognitive domain (memory, attention, executive function), relative comparisons and plain-language summaries. No red/yellow/green risk labels, and no terms like “decline” or “impairment.” Results are signals, not verdicts.

Intentional cut lines for the MVP

Each of these would have introduced regulatory complexity, trust erosion or false authority, so they stayed out of scope:

  • Longitudinal prediction
  • Risk labeling
  • Automated care plans
  • Clinical escalation
Version 2 · Fully digital

From kit to clinician-reviewed service

Orena moved to a fully digital service using licensed BrainCheck Assess. The clinician-in-the-loop model that was on the V1 roadmap is now part of the product: every assessment includes a 1:1 results consultation with a neurologist.

I built the acquisition, onboarding, payments and clinician-review workflows, and designed the current $299 cash-pay offer.

getorena.com
Open ↗
Orena V2 intake: choosing the reason for the assessment.
Metrics

What I measured, and what I deliberately didn’t

Early metrics focused on clarity and completion. Predictive accuracy and long-term outcomes belong in later phases.

  • Assessment completion rate
  • Drop-off points within tasks
  • Time-to-insight
  • Qualitative feedback on confusion vs. reassurance
  • User questions after results, as a signal of trust gaps
Related writing
Build note · Live
Building Orena’s agentic content engine →
An agent-assisted workflow that connects content planning, publishing, and search feedback.
Next case studyElovi →
Sonny Patel
XLinkedIn© 2026 Sonny Patel